Tolebrutinib
CAS: 1971920-73-6
Ref. 3D-FT179188
| 1mg | 234.00 € | ||
| 2mg | 352.00 € | ||
| 5mg | 626.00 € | ||
| 10mg | 895.00 € | ||
| 25mg | 1,403.00 € |
Product Information
Tolebrutinib is an investigational drug that has been shown to have potent inhibitory activity against immune functions. This drug has a number of clinical studies in progress for the treatment of heart disease and autoimmune diseases. Tolebrutinib is being developed by Novartis as a monoclonal antibody, which binds to the target protein Bruton's tyrosine kinase and inhibits its function. The binding of tolebrutinib with the protein prevents it from phosphorylating other proteins, thereby inhibiting their function. The binding of tolebrutinib with the protein also induces reversible covalent modifications at a number of sites on the protein, which may lead to the development of resistance over time.
Chemical properties
Technical inquiry about: 3D-FT179188 Tolebrutinib
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
